Connection
Elizabeth Pomfret to Cost-Benefit Analysis
This is a "connection" page, showing publications Elizabeth Pomfret has written about Cost-Benefit Analysis.
|
|
Connection Strength |
|
|
|
|
|
0.024 |
|
|
|
-
Grafals M, Smith B, Murakami N, Trabucco A, Hamill K, Marangos E, Gilligan H, Pomfret EA, Pomposelli JJ, Simpson MA, Azzi J, Najafian N, Riella LV. Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study. PLoS One. 2014; 9(8):e104408.
Score: 0.024